(R)-1-(3-Methylisoxazole-4-carbonyl)-10a-(6-methylpyridin-3-yl)-2,3,10,10a-tetrahydroimidazo[1,2-a]pyrrolo[1,2-d]pyrazin-5(1H)-one

98%

Reagent Code: #228777
fingerprint
CAS Number 1323077-89-9

science Other reagents with same CAS 1323077-89-9

blur_circular Chemical Specifications

scatter_plot Molecular Information
Weight 377.40 g/mol
Formula C₂₀H₁₉N₅O₃
inventory_2 Storage & Handling
Storage -20°C

description Product Description

Used in the pharmaceutical industry as a key intermediate in the synthesis of antiviral drugs, particularly in the development of NS5A inhibitors for hepatitis C virus (HCV). Its structure supports high binding affinity to the viral NS5A protein, aiding in the inhibition of viral replication and making it valuable for treatments of chronic HCV infections. Commonly applied in research and development stages of drug discovery for RNA viruses, especially hepatitis C.

shopping_cart Available Sizes & Pricing

Size Availability Unit Price Quantity
inventory 5mg
10-20 days ฿54,120.00
inventory 10mg
10-20 days ฿78,430.00
inventory 25mg
10-20 days ฿116,600.00
(R)-1-(3-Methylisoxazole-4-carbonyl)-10a-(6-methylpyridin-3-yl)-2,3,10,10a-tetrahydroimidazo[1,2-a]pyrrolo[1,2-d]pyrazin-5(1H)-one
No image available

Used in the pharmaceutical industry as a key intermediate in the synthesis of antiviral drugs, particularly in the development of NS5A inhibitors for hepatitis C virus (HCV). Its structure supports high binding affinity to the viral NS5A protein, aiding in the inhibition of viral replication and making it valuable for treatments of chronic HCV infections. Commonly applied in research and development stages of drug discovery for RNA viruses, especially hepatitis C.

Used in the pharmaceutical industry as a key intermediate in the synthesis of antiviral drugs, particularly in the development of NS5A inhibitors for hepatitis C virus (HCV). Its structure supports high binding affinity to the viral NS5A protein, aiding in the inhibition of viral replication and making it valuable for treatments of chronic HCV infections. Commonly applied in research and development stages of drug discovery for RNA viruses, especially hepatitis C.

Mechanism -
Appearance -
Longevity -
Strength -
Storage -
Shelf Life -
Allergen(s) -
Dosage (Range) -
Recommended Dosage -
Dosage (Per Day) -
Recommended Dosage (Per Day) -
Mix Method -
Heat Resistance -
Stable in pH range -
Solubility -
Product Types -
INCI -

Purchase History for

Loading purchase history...